Bristows LLP

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Highly-recommended - Firms: transactions

Gold - Firms: litigation

Bristows has made UK patent litigation its own: as of September 2020, it featured in some 26 of the 91 pending cases at the Patents Court. It consistently hammers out the right results in fraught disputes in virtually every industry, which often involve parallel proceedings across Europe and the United States. Highlights in the past 12 months include a headline-grabbing FRAND suit for ZTE and global patent litigation over beer dispensing systems for Heineken. Involved in both is patent litigation co-head and “strategic guru” Andrew Bowler, an “experienced patent litigator who makes life difficult for the other side”: “He is outstanding at picking up on the decisive issues and presenting sharp solutions.” Leading the group alongside Bowler is Myles Jelf, who has also been busy on the ZTE piece, as well as with another crucial FRAND case on behalf of IPCom against companies including Lenovo, HTC, Xiaomi and Vodafone. Working alongside him on the latter mandate is electronics and mechanics litigator Richard Pinckney: “He is sharp, focused and has a real feel for how best to direct a case, achieving excellent results in difficult and demanding time constraints.” Also technically proficient is solicitor-advocate James Boon, who holds a PhD in optoelectronics and handles disputes in fields from 3G to oil and gas. Together with Pinckney, he recently tackled a set of FRAND and SEP-related actions on behalf of Philips. On the life sciences front, the group has dispatched multiple briefs for Novartis in recent months, including a paediatric extension dispute led by Brian Cordery and a patent revocation action led by Gemma Barrett. A favourite of pharmaceutical innovators, Cordery is described by overseas colleagues as “definitely one of the guiding lights of the English patent litigation space”. Barrett – who has an academic background in molecular and cellular biochemistry – “takes a pragmatic and highly effective strategic approach, keeps on top of the science and is a strong team manager”. Further contentious firepower in the life sciences comes from of Dominic Adair, Gregory Bacon, Robert Burrows and Liz Cohen. With a technical background in biology, Adair is “responsive, highly motivated and invests significant time and effort in order to understand the technology”. Bacon is a “great patent litigator who is confident with the technical side of a case, but also has a good tactical legal brain”. “Particularly adept at the science”, Burrows has additionally “mastered the strategic aspects of UK and multi-jurisdictional patent disputes”. Cohen also has a technical background and has been assisting Italian pharmaceutical originator Chiesi Farmaceutici with its patent enforcement strategy: “Once a client works with Liz, they don’t tend to go anywhere else. She has a clear strategic overview of a case, steers litigation in a direction consistent with commercial objectives, and strikes exactly the right balance between pragmatism and aggression.” After a 35-year career during which he appeared in more than 100 patent cases, senior statesman Edward Nodder now manages the group’s relationships with Japanese clients and contacts. The patent transactions team includes Matthew Warren, Claire Smith and Richard Dickinson. Commercial IP head and physicist Warren is great at getting deals involving new technologies inked in all industries. The life sciences is a forte for Smith: “Claire understands the practicalities and legalities of licence, M&A and collaboration agreements, picks up on international issues quickly and is a pragmatic counsellor.” With an academic background in biochemistry, Dickinson understands both the technical and legal sides of the deals he shepherds to close.

Get unlimited access to all IAM content